Bausch Lomb Corp (BLCO)

Bausch Lomb Corp Borsa (BLCO) Ultime notizie

Oct 29, 2026

Bausch & Lomb Is Maintained at Buy by Citigroup - Moomoo

Oct 29, 2026

Oct 29, 2026

Citi Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $23 - Moomoo

Oct 29, 2026

Oct 29, 2026

Bausch + Lomb Corporation (BLCO) Stock forecasts - Yahoo Finance Singapore

Oct 29, 2026

Oct 29, 2026

Stocks in play: Bausch + Lomb Corporation - Yahoo! Finance Canada

Oct 29, 2026

Oct 29, 2026

RBC Raises Price Target on Bausch + Lomb to $23 From $21, Keeps Outperform Rating - marketscreener.com

Oct 29, 2026

Oct 29, 2026

More than 80% of people surveyed with dry eye changed their habits - Stock Titan

Oct 29, 2026

Oct 29, 2026

Bausch + Lomb Corporation 2026 Q3 - Results - Earnings Call Presentation (NYSE:BLCO) 2026-10-29 - Seeking Alpha

Oct 29, 2026

Oct 29, 2026

What Bausch + Lomb (BLCO) Said on Its Q3 Earnings Call - Yahoo Finance

Oct 29, 2026

Oct 29, 2026

Bausch + Lomb Posts Strong Third Quarter Results, Raises Full-Year Guidance - VisionMonday.com

Oct 29, 2026

Oct 28, 2026

Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance - BioSpace

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation Stock 12‑Month Price Target Raised to $19.92, Implies 13% Upside - TradingView

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation (BLCO) Stock Forecasts - Yahoo! Finance Canada

Oct 28, 2026

Oct 28, 2026

Revenue hits $1.38B as Bausch + Lomb (BLCO) turns last year's $28M quarterly loss into a profit. - Stock Titan

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation (BLCO) Stock Forecasts - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

BAUSCH HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS, RAISES GUIDANCE - TradingView

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb: Q3 Earnings Snapshot - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 - marketscreener.com

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation Q3 2026 Earnings Call Summary - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Releases Q3 2026 Financial Results - AlphaStreet

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Posts A Third Beat-And-Raise On Margin Expansion, But An Abrupt CEO Change Clouds The Story - Finviz

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb (BLCO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 28, 2026

Oct 28, 2026

Earnings Flash (BLCO) Bausch + Lomb Corporation Reports Q3 Revenue $1.38B, vs. FactSet Est of $1.37B - www.marketscreener.com

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Corporation (BLCO) Tops Q3 EPS by 13c; offers guidance - StreetInsider

Oct 28, 2026

Oct 28, 2026

Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance - Yahoo Finance

Oct 28, 2026

Oct 27, 2026

Bausch + Lomb (BLCO) reports Q3: everything you need to know ahead of earnings - Yahoo Finance

Oct 27, 2026

Oct 23, 2026

Bausch + Lomb Corporation Estimates – NYSE:BLCO - TradingView

Oct 23, 2026

Oct 22, 2026

Earnings Preview: BLCO to Report Financial Results Pre-market on October 28 - Moomoo

Oct 22, 2026

Oct 22, 2026

Bausch + Lomb Announces Board of Directors Update - Medical Product Outsourcing

Oct 22, 2026

Oct 22, 2026

Enterprise value to revenue forward of Bausch + Lomb Corporation – DUS:S2L - TradingView

Oct 22, 2026

Oct 20, 2026

MarketBeat cites USD 19.46 target for Bausch + Lomb stock - ad-hoc-news.de

Oct 20, 2026

Oct 19, 2026

Billionaire Investor Took a Stake in Bausch + Lomb Before Its CEO Shake-Up - Benzinga

Oct 19, 2026

Oct 17, 2026

Bausch + Lomb Corporation (BLCO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 17, 2026

Oct 16, 2026

Bausch + Lomb Corp. (S2L.SG) Q2 FY2026 earnings call transcript - Yahoo Finance

Oct 16, 2026

Oct 14, 2026

Bausch + Lomb's oral dry AMD therapy advances to clinical evaluation - Glance by Eyes On Eyecare

Oct 14, 2026

Oct 13, 2026

Bausch + Lomb Corporation Announces Cessation of Brent Saunders as Director, Effective October 12, 2026 - marketscreener.com

Oct 13, 2026

Oct 12, 2026

Bausch + Lomb Corporation (BLCO) Stock Forecasts - Yahoo Finance

Oct 12, 2026

Oct 12, 2026

Bausch + Lomb CEO Saunders departs, Chairman Appio named interim chief - Reuters

Oct 12, 2026

Oct 12, 2026

Thomas J. Appio Named Interim CEO of Bausch + Lomb as Brent Saunders Departs - VisionMonday.com

Oct 12, 2026

Oct 12, 2026

What Could Bausch Health (TSX:BHC) Reveal in Its Next Results? - Kalkine Media

Oct 12, 2026

Oct 12, 2026

Bausch + Lomb names Appio interim CEO as Saunders departs - StreetInsider

Oct 12, 2026

Oct 12, 2026

Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance - Yahoo Finance

Oct 12, 2026

Oct 12, 2026

Bausch Health's CEO now also leads Bausch + Lomb as interim CEO. - Stock Titan

Oct 12, 2026

Oct 12, 2026

Bausch + Lomb Corporation and Bausch Health Companies Inc. Announce CEO Changes - www.marketscreener.com

Oct 12, 2026

Oct 12, 2026

Why Is Bausch + Lomb Stock Falling Monday? - Bausch Health Companies (NYSE:BHC), Bausch & Lomb (NYSE:BLCO - Benzinga

Oct 12, 2026

Oct 12, 2026

Bausch + Lomb CEO Brent Saunders departs, for a second time - FirstWord Pharma

Oct 12, 2026

Oct 09, 2026

Barclays Initiates Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Announces Target Price $24 - Moomoo

Oct 09, 2026

Oct 09, 2026

RBC Capital Remains a Buy on Bausch + Lomb Corporation (BLCO) - The Globe and Mail

Oct 09, 2026

Oct 08, 2026

Bausch + Lomb's Dry Eye Disease Prescription Momentum Builds, Forex Turns as Modest Headwind in Q3, RBC Says - marketscreener.com

Oct 08, 2026

Oct 08, 2026

Barclays Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO) - The Globe and Mail

Oct 08, 2026

Oct 07, 2026

Bausch & Lomb Initiated at Overweight by Barclays - Moomoo

Oct 07, 2026